SET
Reactivité: Humain
Hôte: Synthetic
BP, IHC, WB, IP
N° du produit ABIN983601
Aperçu rapide pour SET Nuclear Oncogene (SET) (N-Term) Peptide (ABIN983601)
Antigène
SET/TAF-I (SET)
(SET Nuclear Oncogene (SET))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP)
Protein Region
N-Term
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-SET antibody (Catalog #: ARP56542_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
SET/TAF-I (SET)
(SET Nuclear Oncogene (SET))
Sujet
SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-indu
Alias Symbols: 2PP2A, I2PP2A, IGAAD, PHAPII, TAF-IBETA, TAF-I, IPP2A2
Protein Interaction Partner: ANP32A,APEX1,CDK5,CDK5R1,CDKN1A,ELAVL1,EP300,GZMA,HIST2H4A,HIST3H3,HMGB2,KLF5,MLL,NME1,PPP2CA,PPP2R1B,PTMA,RAC1,SET,SETBP1,SGOL1,TAF1A,THAP7,ANP32A,APEX1,CDK5R1,CDKN1A,DGKE,GZMA,HIST3H3,HIST4H4,HMGB2,KLF5,MEPCE,NME1,OTUD5,RGS20,SETBP1,TAF1A,THAP7,USP17L2,USP46,WDR48